Cargando…
SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas
BACKGROUND: High toxicity, morbidity and secondary malignancy render chemotherapy of neuroblastoma inefficient, prompting the search for novel compounds. Nanovesicles offer great promise in imaging and treatment of cancer. SapC-DOPS, a stable nanovesicle formed from the lysosomal protein saposin C a...
Autores principales: | Sulaiman, Mahaboob K, Chu, Zhengtao, Blanco, Victor M, Vallabhapurapu, Subrahmanya D, Franco, Robert S, Qi, Xiaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397704/ https://www.ncbi.nlm.nih.gov/pubmed/25889084 http://dx.doi.org/10.1186/s12943-015-0336-y |
Ejemplares similares
-
Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors
por: Blanco, Víctor M., et al.
Publicado: (2014) -
Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles
por: Davis, Harold W., et al.
Publicado: (2019) -
Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles
por: Davis, Harold W., et al.
Publicado: (2020) -
Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer
por: Chu, Zhengtao, et al.
Publicado: (2013) -
Detection of cancer cells using SapC-DOPS nanovesicles
por: Davis, Harold W., et al.
Publicado: (2016)